Proteomic signatures improve risk prediction for common and rare diseases
Julia Carrasco-Zanini(Queen Mary University of London), Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Daniel F. Freitag(Bayer (Germany)), Ana Torralbo(University College London), Chloe Robins(Institut thématique Génétique, génomique et bioinformatique), Damien C. Croteau‐Chonka(University of North Carolina at Chapel Hill), Simon Haas(German Cancer Research Center), Joanna Betts(GlaxoSmithKline (United Kingdom)), C. R. Ytsma(Wellcome Centre for Anti-Infectives Research), Christopher Tomlinson(National Institute for Health and Care Research), Florian Grünschläger(German Cancer Research Center), Tokuwa Kanno, Spiros Denaxas(University College London), Jonathan Davitte(GlaxoSmithKline (United States)), Frederik Ziebell, Nicholas J. Wareham(University of Cambridge), Praveen Surendran(University of Cambridge), Harry Hemingway(Health Data Research UK), Natalie Fitzpatrick(University College London), Robert A. Scott(Age UK), Stephan Gade, Maik Pietzner(University of Freiburg)
Cited by 189